Efalizumab-associated papular psoriasis: An advers...[J Dermatolog Treat. 2008]

SearchDatabase nameforSearch term

Advanced Search (beta)

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: J Dermatolog Treat. 2008 Jul 9:1-2. [Epub ahead of print] Links

Efalizumab-associated papular psoriasis: An adverse reaction to efalizumab in three cases.

Antonucci A, Bardazzi F, Balestri R, Patrizi A.

Department of Specialistic and Experimental Clinical Medicine, Division of Dermatology, University of Bologna, Bologna, Italy.

Efalizumab-associated papular psoriasis is a common adverse event caused by efalizumab therapy. This clinical manifestation is characterized by a transient papular eruption localized especially on the flexural areas and on the back. We report three cases of efalizumab-associated papular psoriasis.

PMID: 18618361 [PubMed - as supplied by publisher]

Efalizumab-associated papular psoriasis. [Arch Dermatol. 2007]
Clinical considerations of efalizumab therapy in patients with psoriasis. [Semin Cutan Med Surg. 2005]
The Greek experience with efalizumab in psoriasis from a University Dermatologic Hospital. [Br J Dermatol. 2007]
Etanercept and efalizumab for the treatment of psoriasis: a systematic review. [Health Technol Assess. 2006]
Efalizumab: a review of events reported during clinical trials and side effects. [Expert Opin Drug Saf. 2006]
» See all Related Articles...

Display Show

Efalizumab-associated papular psoriasis: An adverse reaction to efalizumab in three cases.

Related Articles